Home › NDC Lookup › Labelers › Ucb, Inc.

Ucb, Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 50474 (Ucb, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

58
Package NDCs
52
Products
52
Active listings
0
Discontinued
9
Ingredients
1
Therapeutic classes
10
Dosage forms
28
With NADAC pricing

Portfolio

By therapeutic class
ANTICONVULSANT - BENZODIAZEPINE TY... 1
Top ingredients
brivaracetam 14
rotigotine 14
levetiracetam 8
bimekizumab 4
ROZANOLIXIZUMAB 4
certolizumab pegol 3
zilucoplan 3
doxecitine and doxribtimine 1
midazolam 1
By dosage form
TABLET, FILM COATED 14
INJECTION, SOLUTION 13
PATCH, EXTENDED RELEASE 12
SOLUTION 3
KIT 3
INJECTION, SUSPENSION 2
TABLET, FILM COATED, EXTENDED RELE... 2
INJECTION, SOLUTION, CONCENTRATE 1

Browse records — 52 products

Drug / product Billing NDC NADAC / unit Status
Bimzelx bimekizumab 160 mg/mL INJECTION, SOLUTION UCB, · NDC 50474-0781-85 · 2 SYRINGE, GLASS in 1 CARTON (50474-781-85) / 1 mL in 1 SYRINGE, GLASS 50474-0781-85 $8,112.590 /unit · NADAC On market View →
Bimzelx bimekizumab 160 mg/mL INJECTION, SOLUTION UCB, · NDC 50474-0780-79 · 2 SYRINGE, GLASS in 1 CARTON (50474-780-79) / 1 mL in 1 SYRINGE, GLASS 50474-0780-79 — On market View →
Bimzelx bimekizumab 320 mg/2mL INJECTION, SOLUTION UCB, · NDC 50474-0783-78 · 1 SYRINGE, GLASS in 1 CARTON (50474-783-78) / 2 mL in 1 SYRINGE, GLASS 50474-0783-78 — On market View →
Bimzelx bimekizumab 320 mg/2mL INJECTION, SOLUTION UCB, · NDC 50474-0782-84 · 1 SYRINGE, GLASS in 1 CARTON (50474-782-84) / 2 mL in 1 SYRINGE, GLASS 50474-0782-84 $8,016.040 /unit · NADAC On market View →
Briviact brivaracetam 100 mg/1 TABLET, FILM COATED UCB, · NDC 50474-0770-09 · 100 BLISTER PACK in 1 CARTON (50474-770-09) / 1 TABLET, FILM COATED in 1 BLISTER PACK 50474-0770-09 $24.076 /unit · NADAC On market View →
Briviact brivaracetam 25 mg/1 TABLET, FILM COATED UCB, · NDC 50474-0470-09 · 100 BLISTER PACK in 1 CARTON (50474-470-09) / 1 TABLET, FILM COATED in 1 BLISTER PACK 50474-0470-09 $24.066 /unit · NADAC On market View →
Briviact brivaracetam 10 mg/1 TABLET, FILM COATED UCB, · NDC 50474-0370-66 · 1 BOTTLE in 1 CARTON (50474-370-66) / 60 TABLET, FILM COATED in 1 BOTTLE 50474-0370-66 $23.986 /unit · NADAC On market View →
Briviact brivaracetam 10 mg/mL SOLUTION UCB, · NDC 50474-0870-15 · 1 BOTTLE in 1 CARTON (50474-870-15) / 300 mL in 1 BOTTLE 50474-0870-15 $4.810 /unit · NADAC On market View →
Briviact brivaracetam 50 mg/5mL INJECTION, SUSPENSION UCB, · NDC 50474-0970-75 · 10 VIAL, GLASS in 1 CARTON (50474-970-75) / 5 mL in 1 VIAL, GLASS (50474-970-63) 50474-0970-75 — On market View →
Briviact brivaracetam 75 mg/1 TABLET, FILM COATED UCB, · NDC 50474-0670-66 · 1 BOTTLE in 1 CARTON (50474-670-66) / 60 TABLET, FILM COATED in 1 BOTTLE 50474-0670-66 $24.049 /unit · NADAC On market View →
Briviact brivaracetam 50 mg/1 TABLET, FILM COATED UCB, · NDC 50474-0570-09 · 100 BLISTER PACK in 1 CARTON (50474-570-09) / 1 TABLET, FILM COATED in 1 BLISTER PACK 50474-0570-09 $24.080 /unit · NADAC On market View →
Briviact brivaracetam 25 mg/1 TABLET, FILM COATED UCB, · NDC 50474-0470-09 · 100 BLISTER PACK in 1 CARTON (50474-470-09) / 1 TABLET, FILM COATED in 1 BLISTER PACK 50474-0470-09 $24.066 /unit · NADAC On market View →
Briviact brivaracetam 75 mg/1 TABLET, FILM COATED UCB, · NDC 50474-0670-66 · 1 BOTTLE in 1 CARTON (50474-670-66) / 60 TABLET, FILM COATED in 1 BOTTLE 50474-0670-66 $24.049 /unit · NADAC On market View →
Briviact brivaracetam 100 mg/1 TABLET, FILM COATED UCB, · NDC 50474-0770-09 · 100 BLISTER PACK in 1 CARTON (50474-770-09) / 1 TABLET, FILM COATED in 1 BLISTER PACK 50474-0770-09 $24.076 /unit · NADAC On market View →
Briviact brivaracetam 50 mg/1 TABLET, FILM COATED UCB, · NDC 50474-0570-09 · 100 BLISTER PACK in 1 CARTON (50474-570-09) / 1 TABLET, FILM COATED in 1 BLISTER PACK 50474-0570-09 $24.080 /unit · NADAC On market View →
Briviact brivaracetam 50 mg/5mL INJECTION, SUSPENSION UCB, · NDC 50474-0970-75 · 10 VIAL, GLASS in 1 CARTON (50474-970-75) / 5 mL in 1 VIAL, GLASS (50474-970-63) 50474-0970-75 — On market View →
Briviact brivaracetam 10 mg/mL SOLUTION UCB, · NDC 50474-0870-15 · 1 BOTTLE in 1 CARTON (50474-870-15) / 300 mL in 1 BOTTLE 50474-0870-15 $4.810 /unit · NADAC On market View →
Briviact brivaracetam 10 mg/1 TABLET, FILM COATED UCB, · NDC 50474-0370-66 · 1 BOTTLE in 1 CARTON (50474-370-66) / 60 TABLET, FILM COATED in 1 BOTTLE 50474-0370-66 $23.986 /unit · NADAC On market View →
Cimzia certolizumab pegol 200 mg/mL INJECTION, SOLUTION UCB, · NDC 50474-0710-79 · J0717 · 2 SYRINGE, GLASS in 1 CARTON (50474-710-79) / 1 mL in 1 SYRINGE, GLASS 50474-0710-79 $6,094.020 /unit · NADAC On market View →
Cimzia certolizumab pegol KIT UCB, · NDC 50474-0700-61 · 2 KIT in 1 CARTON (50474-700-61) / 1 KIT in 1 KIT * 1 mL in 1 VIAL, GLASS * 1 mL in 1 VIAL, GLASS 50474-0700-61 — On market View →
Cimzia certolizumab pegol 200 mg/mL INJECTION, SOLUTION UCB, · NDC 50474-0750-10 · J0717 · 1 SYRINGE, GLASS in 1 CARTON (50474-750-10) / 1 mL in 1 SYRINGE, GLASS 50474-0750-10 — On market View →
Keppra levetiracetam 250 mg/1 TABLET, FILM COATED UCB, · NDC 50474-0594-40 · 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50474-594-40) 50474-0594-40 $8.079 /unit · NADAC On market View →
Keppra levetiracetam 100 mg/mL INJECTION, SOLUTION, CONCENTRATE UCB, · NDC 50474-0002-63 · J1953 · 10 VIAL, SINGLE-USE in 1 CARTON (50474-002-63) / 5 mL in 1 VIAL, SINGLE-USE 50474-0002-63 — On market View →
Keppra levetiracetam 750 mg/1 TABLET, FILM COATED UCB, · NDC 50474-0596-40 · 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50474-596-40) 50474-0596-40 $13.461 /unit · NADAC On market View →
Keppra levetiracetam 1000 mg/1 TABLET, FILM COATED UCB, · NDC 50474-0597-66 · 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50474-597-66) 50474-0597-66 $19.877 /unit · NADAC On market View →
Keppra levetiracetam 100 mg/mL SOLUTION UCB, · NDC 50474-0001-48 · 473 mL in 1 BOTTLE, PLASTIC (50474-001-48) 50474-0001-48 $1.919 /unit · NADAC On market View →
Keppra levetiracetam 500 mg/1 TABLET, FILM COATED UCB, · NDC 50474-0595-40 · 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50474-595-40) 50474-0595-40 $9.916 /unit · NADAC On market View →
Keppra XR levetiracetam 750 mg/1 TABLET, FILM COATED, EXTENDED RELEASE UCB, · NDC 50474-0599-66 · 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50474-599-66) 50474-0599-66 $13.493 /unit · NADAC On market View →
Keppra XR levetiracetam 500 mg/1 TABLET, FILM COATED, EXTENDED RELEASE UCB, · NDC 50474-0598-66 · 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50474-598-66) 50474-0598-66 $9.031 /unit · NADAC On market View →
KYGEVVI doxecitine and doxribtimine 2 g/1; 2 g/1 POWDER, FOR SOLUTION UCB, · NDC 50474-0350-30 · 30 PACKET in 1 CARTON (50474-350-30) / 1 POWDER, FOR SOLUTION in 1 PACKET (50474-350-01) 50474-0350-30 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.